Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Biogen Nasdaq NYSE Eli Lilly And Co Alzheimer Disease Disease FDA Roche
  • One of the most-watched Alzheimer's therapies in the clinic, Biogen Inc (NASDAQ:BIIB)-Eisai Limited's (OTC:ESALY) experimental lecanemab reduced clinical decline on the scale by 27% compared to the placebo at 18 months in early Alzheimer's.
  • In July 2022, the FDA accepted the marketing application for lecanemab under the accelerated approval pathway and granted a Priority Review. The PDUFA date is Jan. 6, 2023. 
  • Also Read: This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval.
  • Several stocks related to Alzheimer's programs are gaining. SVB Leerink said these positive results would reinvigorate the Alzheimer's space.

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Does your sleep tracker get it right? A Pittsburgh neuroscientist weighs in
On a typical night, I go to bed wearing a tracking watch on one wrist and another type of tracker on the other wrist. Then I compare their sleep findings while I drink my morning coffee.
The Conversation
The Conversation
There's A Reason Taxi Cabs Are Almost Always Yellow
Yellow taxis are easy to spot in traffic, but the color's history goes far beyond simple visibility.
Motor1
Motor1
How ‘technoference’ can disrupt parent-child connections
Have you ever been telling someone a story when their phone lights up, and their eyes flicker toward their device?
The Conversation
The Conversation
Holding Lightning by Emily Lordi review – an intimate portrait of Whitney Houston
An empathetic biography of the the singer recasts her tumultuous later career as a triumph of self-expression
The Guardian - UK
The Guardian - UK
Brian May says Queen are retiring from live tours: ‘Maybe 50 years is enough’
Rock guitarist suggested creating an interactive experience for fans similar to the ‘Abba Voyage’ show
The Independent UK
The Independent UK
"Lanterns" finds its power in fear
To fulfill his destiny, John Stewart embraces what he was trained to reject — and so should we
Salon
Salon
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play